← Leaderboards
Satheesh B Ravula
Epigen Biosciences, Inc.
$2,140,663
Attributed
$4,163,590
Total exposure
5
Grants
4
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.3M · FY2012–21$2M$1.5M$1M$500K$0
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
Funding mix
By agency
NIH$4,163,590 · 5
By mechanism
R44$2,491,861 · 1
R41$996,745 · 2
R43$674,984 · 2
Top collaborators
- Tony L Yaksh3 shared
- Rivkah R Isseroff2 shared
- Kevin Ron Nash2 shared
- John A Schetz2 shared
- Katherine E Conant1 shared
- Raymond Scott Turner1 shared
Most similar at Epigen Biosciences, Inc.
Same institution · by research overlap
- Fabio Cohen Tucci$6,913,476
- Graham Beaton$1,190,053
- Kevin Bacon$149,473
Others in their field
Top investigators on “Alzheimer&Apos”
- Jose A Luchsinger · Columbia University Health Sciences$56,595,040
- Eric M Reiman · Banner Health$48,982,487
- Yadong Huang · J. David Gladstone Institutes$40,311,515
- Lindsay A. Farrer · Boston University Medical Campus$34,189,802
- David M Holtzman · Washington University$28,985,806
- Michael W Weiner · Northern California Institute Res &Educ$28,197,224
Research focus
Alzheimer&AposMouse ModelSmall MoleculeLeadIn VitroPropertyResponsePharmaceutical PreparationsDoseIn VivoBaseBehavioralLigandsLiteratureBiochemicalProteinsPharmacophoreEpigenMedicalDrug DiscoveryDesignLead OptimizationLiver MicrosomesG-Protein-Coupled Receptors
Grant awards (8)
Evaluation of Alzheimers disease experimental small molecule therapeutics in the models of Amyotrophic lateral sclerosis$449,984
R43 · FY2021 · AG · contact PI
Lead optimization and development of novel targeted small molecule therapeutics for Alzheimers disease$1,322,759
R44 · FY2020 · AG · contact PI
Lead optimization and development of novel targeted small molecule therapeutics for Alzheimers disease$1,169,102
R44 · FY2019 · AG · contact PI
New Approach to Atopic Dermatitis$225,000
R43 · FY2018 · AR · contact PI
Discovery of novel small molecule analgesics$244,999
R41 · FY2014 · NS · contact PI
I-Corps training for 1R41NS086244-A01 Discovery of novel small molecule analgesics$25,000
R41 · FY2014 · NS · contact PI
Drug regulators of nitric oxide production as Alzheimer's disease therapeutics$386,112
R41 · FY2013 · AG
Druggable regulators of nitric oxide production as new Alzheimer's disease therap$340,634
R41 · FY2012 · AG